CX Institutional’s National Healthcare NHC Stock Holding History

CX Institutional’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18	Closed	-$1K	–	902
2019 Q2	$1K	Buy	+18	New	+$1.39K	﹤0.01%	876

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CX Institutional's NHC Position: Q3 2019 in Review

CX Institutional sold out of National Healthcare (NHC) in Q3 2019, closing a stake of 18 shares — an estimated $1K sold.

CX Institutional first reported a position in NHC in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 137 funds tracked by Wall St. Rank hold NHC as of Q3 2019.

CX Institutional reported no remaining National Healthcare position as of Q3 2019 after selling out during the quarter.
CX Institutional sold 18 National Healthcare shares in Q3 2019, an estimated $1K.
CX Institutional first reported a position in National Healthcare in Q2 2019 and held it in 1 quarter.
CX Institutional's National Healthcare position peaked at $1K in Q2 2019.
137 funds tracked by Wall St. Rank held National Healthcare as of Q3 2019.

Based on CX Institutional's 13F filing for Q3 2019, filed 10 Oct 2019.